Fingerprint
Dive into the research topics of 'E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor–Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically